IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis

Cell

Volumn 131, Issue 4, 2007, Pages 669-681

  Varfolomeev, Eugene ^a   Blankenship, John W ^a   Wayson, Sarah M ^a   Fedorova, Anna V ^a   Kayagaki, Nobuhiko ^a   Garg, Parie ^a   Zobel, Kerry ^a   Dynek, Jasmin N ^a   Elliott, Linda O ^a   Wallweber, Heidi J A ^a   Flygare, John A ^a   Fairbrother, Wayne J ^a   Deshayes, Kurt ^a   Dixit, Vishva M ^a   Vucic, Domagoj ^a  

^a GENENTECH INC   (United States)

Author keywords

CELLBIO; HUMDISEASE; SIGNALING

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; INHIBITOR OF APOPTOSIS PROTEIN ANTAGONIST; PROTEASOME; PROTEIN INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME DEGRADATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UBIQUITINATION;

INTRACISTERNAL A-PARTICLES;

EID: 36048999753     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2007.10.030     Document Type: Article

References (51)

1. Annunziata C.M., Davis R.E., Demchenko Y., Bellamy W., Gabrea A., Zhan F., Lenz G., Hanamura I., Wright G., Xiao W., et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12 (2007) 115-130
2. Ashkenazi A., and Dixit V.M. Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11 (1999) 255-260
3. Budihardjo I., Oliver H., Lutter M., Luo X., and Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15 (1999) 269-290
4. Chen G., and Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 296 (2002) 1634-1635
5. Chen Z.J. Ubiquitin signalling in the NF-kappaB pathway. Nat. Cell Biol. 7 (2005) 758-765
6. Du C., Fang M., Li Y., Li L., and Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102 (2000) 33-42
7. Franken N.A., Rodermond H.M., Stap J., Haveman J., and van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 1 (2006) 2315-2319
8. Gao Z., Tian Y., Wang J., Yin Q., Wu H., Li Y.M., and Jiang X. A dimeric Smac/diablo peptide directly relieves caspase-3 inhibition by XIAP: Dynamic and cooperative regulation of XIAP by Smac/diablo. J. Biol. Chem. (2007) in press
9. Grech A.P., Amesbury M., Chan T., Gardam S., Basten A., and Brink R. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-κB activation in mature B cells. Immunity 21 (2004) 629-642
10. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev. 18 (2004) 2195-2224
11. Hofmann K., Bucher P., and Tschopp J. The CARD domain: a new apoptotic signalling motif. Trends Biochem. Sci. 22 (1997) 155-156
12. Hunter A.M., Lacasse E.C., and Korneluk R.G. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12 (2007) 1543-1568
13. Johnston M.D., Finter N.B., and Young P.A. Dye uptake method for assay of interferon activity. Methods Enzymol. 78 (1981) 394-399
14. Kaufmann S.H., and Vaux D.L. Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene 22 (2003) 7414-7430
15. Keats J.J., Fonseca R., Chesi M., Schop R., Baker A., Chng W.J., Van Wier S., Tiedemann R., Shi C.X., Sebag M., et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 12 (2007) 131-144
16. Li L., Thomas R.M., Suzuki H., De Brabander J.K., Wang X., and Harran P.G. A small molecule Smac mimic potentiates TRAIL- and TNFα-mediated cell death. Science 305 (2004) 1471-1474
17. Li X., Yang Y., and Ashwell J.D. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416 (2002) 345-347
18. Liston P., Fong W.G., and Korneluk R.G. The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 22 (2003) 8568-8580
19. Liu Z., Sun C., Olejniczak E.T., Meadows R.P., Betz S.F., Oost T., Herrmann J., Wu J.C., and Fesik S.W. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature 408 (2000) 1004-1008
20. Micheau O., and Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114 (2003) 181-190
21. Miller L.K. An exegesis of IAPs: salvation and surprises from BIR motifs. Trends Cell Biol. 9 (1999) 323-328
22. Oost T.K., Sun C., Armstrong R.C., Al-Assaad A.S., Betz S.F., Deckwerth T.L., Ding H., Elmore S.W., Meadows R.P., Olejniczak E.T., et al. Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer. J. Med. Chem. 47 (2004) 4417-4426
23. Reed J.C. Apoptosis-targeted therapies for cancer. Cancer Cell 3 (2003) 17-22
24. Rothe M., Pan M.G., Henzel W.J., Ayres T.M., and Goeddel D.V. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83 (1995) 1243-1252
25. Rothe M., Wong S.C., Henzel W.J., and Goeddel D.V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78 (1994) 681-692
26. Salvesen G.S., and Abrams J.M. Caspase activation - stepping on the gas or releasing the brakes? Lessons from humans and flies. Oncogene 23 (2004) 2774-2784
27. Salvesen G.S., and Duckett C.S. IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3 (2002) 401-410
28. Samuel T., Welsh K., Lober T., Togo S.H., Zapata J.M., and Reed J.C. Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases. J. Biol. Chem. 281 (2006) 1080-1090
29. Scheidereit C. IκB kinase complexes: gateways to NF-κB activation and transcription. Oncogene 25 (2006) 6685-6705
30. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G., Chen Y., Hu Y., Fong A., Sun S.C., and Karin M. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 293 (2001) 1495-1499
31. Sharma S.K., Straub C., and Zawel L. Development of peptidomimetics targeting IAPs. International Journal of Peptide Research and Therapeutics 12 (2006) 21-32
32. Sharp D.A., Lawrence D.A., and Ashkenazi A. Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. J. Biol. Chem. 280 (2005) 19401-19409
33. Shu H.B., Takeuchi M., and Goeddel D.V. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc. Natl. Acad. Sci. USA 93 (1996) 13973-13978
34. Steller H. Mechanisms and genes of cellular suicide. Science 267 (1995) 1445-1449
35. Sun H., Nikolovska-Coleska Z., Yang C.Y., Xu L., Liu M., Tomita Y., Pan H., Yoshioka Y., Krajewski K., Roller P.P., and Wang S. Structure-based design of potent, conformationally constrained Smac mimetics. J. Am. Chem. Soc. 126 (2004) 16686-16687
36. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
37. Varfolomeev E., Maecker H., Sharp D., Lawrence D., Renz M., Vucic D., and Ashkenazi A. Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand. J. Biol. Chem. 280 (2005) 40599-40608
38. Varfolomeev E., Wayson S.M., Dixit V.M., Fairbrother W.J., and Vucic D. The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-κB activation independently of TRAF1 AND TRAF2. J. Biol. Chem. 281 (2006) 29022-29029
39. Vaux D.L., and Silke J. IAPs, RINGs and ubiquitylation. Nat. Rev. Mol. Cell Biol. 6 (2005) 287-297
40. Verhagen A.M., Ekert P.G., Pakusch M., Silke J., Connolly L.M., Reid G.E., Moritz R.L., Simpson R.J., and Vaux D.L. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102 (2000) 43-53
41. Vucic D., Deshayes K., Ackerly H., Pisabarro M.T., Kadkhodayan S., Fairbrother W.J., and Dixit V.M. SMAC Negatively Regulates the Anti-apoptotic Activity of Melanoma Inhibitor of Apoptosis (ML-IAP). J. Biol. Chem. 277 (2002) 12275-12279
42. Vucic D., Franklin M.C., Wallweber H.J., Das K., Eckelman B.P., Shin H., Elliott L.O., Kadkhodayan S., Deshayes K., Salvesen G.S., and Fairbrother W.J. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP. Biochem. J. 385 (2005) 11-20
43. Vucic D., Stennicke H.R., Pisabarro M.T., Salvesen G.S., and Dixit V.M. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr. Biol. 10 (2000) 1359-1366
44. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., and Baldwin Jr. A.S. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281 (1998) 1680-1683
45. Wertz I.E., O'Rourke K.M., Zhou H., Eby M., Aravind L., Seshagiri S., Wu P., Wiesmann C., Baker R., Boone D.L., et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430 (2004) 694-699
46. Wu G., Chai J., Suber T.L., Wu J.W., Du C., Wang X., and Shi Y. Structural basis of IAP recognition by Smac/DIABLO. Nature 408 (2000) 1008-1012
47. Xiao G., Harhaj E.W., and Sun S.C. NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell 7 (2001) 401-409
48. Yang Q.H., and Du C. Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells. J. Biol. Chem. 279 (2004) 16963-16970
49. Yang Y., Fang S., Jensen J.P., Weissman A.M., and Ashwell J.D. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288 (2000) 874-877
50. Zender L., Spector M.S., Xue W., Flemming P., Cordon-Cardo C., Silke J., Fan S.T., Luk J.M., Wigler M., Hannon G.J., et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125 (2006) 1253-1267
51. Zobel K., Wang L., Varfolomeev E., Franklin M.C., Elliott L.O., Wallweber H.J., Okawa D.C., Flygare J.A., Vucic D., Fairbrother W.J., and Deshayes K. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs. ACS Chem Biol 1 (2006) 525-533